1. Home
  2. NHC vs ARQT Comparison

NHC vs ARQT Comparison

Compare NHC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

HOLD

Current Price

$225.87

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$27.30

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHC
ARQT
Founded
1971
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
NHC
ARQT
Price
$225.87
$27.30
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$34.00
AVG Volume (30 Days)
111.1K
1.4M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.46%
N/A
EPS Growth
17.46
88.79
EPS
2.27
N/A
Revenue
$1,517,781,000.00
$376,072,000.00
Revenue This Year
N/A
$34.85
Revenue Next Year
N/A
$29.39
P/E Ratio
$97.58
N/A
Revenue Growth
16.09
91.34
52 Week Low
$94.04
$13.70
52 Week High
$232.25
$31.77

Technical Indicators

Market Signals
Indicator
NHC
ARQT
Relative Strength Index (RSI) 64.23 53.86
Support Level $154.31 $24.96
Resistance Level N/A $27.79
Average True Range (ATR) 7.73 1.25
MACD 0.06 -0.19
Stochastic Oscillator 77.25 32.90

Price Performance

Historical Comparison
NHC
ARQT

About NHC National HealthCare Corporation

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: